Early experience with selexipag for the treatment of adults with pulmonary arterial hypertension associated with congenital heart disease

Back

ESC Premium Access

Early experience with selexipag for the treatment of adults with pulmonary arterial hypertension associated with congenital heart disease

Session: Congenital Heart Disease and Pediatric Cardiology ePosters

Topic: Pharmacotherapy

Speaker: Ms A. van Dissel (Amsterdam, NL)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Ms Alexandra van Dissel

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

1 presentation

0 follower

43 more presentations in this session

Suppression of myocardial HIF-1 by pubertal insulin resistance compromises metabolic adaptation and impairs cardiac function in patients with cyanotic congenital heart disease

Speaker: Doctor Y. Liu (Shanghai, CN)

Access

Abstract

Slides

Response to fluid challenge in patients with atrial septal defect

Speaker: Doctor M. D'Alto (Naples, IT)

Access

Abstract

Slides

Family screening in patients with isolated bicuspid aortic valve in a general hospital, yield and subgroup analysis

Speaker: Doctor L. Cozijnsen (Apeldoorn, NL)

Access

Abstract

Slides

Risk of ischemic stroke in adult patients with congenital heart disease

Speaker: Doctor K. Giang (Gothenburg, SE)

Access

Abstract

Slides

Risk of infective endocarditis among patients with tetralogy of fallot

Speaker: Miss E. Havers-Borgersen (Copenhagen, DK)

Access

Abstract

Slides

Access the full session

Congenital Heart Disease and Pediatric Cardiology ePosters

Speakers: Ms A. van Dissel, Doctor Y. Liu, Doctor M. D'Alto, Doctor L. Cozijnsen, Doctor K. Giang...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources